Literature DB >> 6439451

Further immunological studies of sera containing anti-mitochondrial antibodies, type M 5.

R Norberg, B Gårdlund, R Thorstensson, K Lidman.   

Abstract

All of 15 sera containing anti-mitochondrial antibodies (AMA), type M 5, reacted in ELISA with ssDNA, whereas only four had anti-nuclear antibodies as demonstrated by immunofluorescence technique. Twelve of 15 had biological false-positive seroreaction for syphilis and seven of 11 cases investigated had a positive lupus anti-coagulant test. Cold agglutinins were present in 11 sera. Hyper-gamma-globulinaemia was not a prominent finding, but C4 values below the lower limit were common in spite of C3 within the normal range. Absorption of IgG fractions from three different sera with cardiolipin eliminated the reaction with ssDNA and mitochondria, supporting a certain degree of cross-reactivity among the antibodies. The presence of AMA, type M 5, seemed to discriminate a group of patients with symptoms often consistent with SLE although some of the most prominent findings were often absent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439451      PMCID: PMC1577109     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5.

Authors:  M T Labro; M C Andrieu; M Weber; J C Homberg
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  Clinical and immunological significance of antibodies to Ro and La in systemic lupus erythematosus.

Authors:  M Reichlin
Journal:  Arthritis Rheum       Date:  1982-07

4.  Hybridoma autoantibodies to DNA.

Authors:  C Andrzejewski; B D Stollar; T M Lalor; R S Schwartz
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA.

Authors:  C Andrzejewski; J Rauch; E Lafer; B D Stollar; R S Schwartz
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus.

Authors:  B Gårdlund
Journal:  Acta Med Scand       Date:  1984

7.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens.

Authors:  F Meek; E L Khoury; D Doniach; H Baum
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

View more
  12 in total

1.  Antimitochondrial antibodies in the antiphospholipid syndrome.

Authors:  N Abuaf; S Laperche; R Carsique; O Meyer; A Deschamps; B Rajoely; C Johanet; J C Homberg
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

2.  Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies.

Authors:  L La Rosa; G Covini; C Galperin; L Catelli; N Del Papa; G Reina; A Morabito; G Balestrieri; A Tincani; M E Gershwin; P L Meroni
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Affinity of human carcinoma cell nuclei for polyinosinic acid demonstrated by monoclonal antibodies.

Authors:  J Jonsson; G Auer; K Erhardt; W Schilling; C Orvell; A Fagraeus
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

4.  Detection of anti-mitochondrial antibodies by ELISA and Western-blot techniques and identification by one and two-dimensional gel electrophoresis of M2 target antigens.

Authors:  G Dighiero; C Magnac; J de Saint Martin; N Abuaf
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

5.  Anti-mitochondrial type 5 antibodies and anti-cardiolipin antibodies in systemic lupus erythematosus and auto-immune diseases.

Authors:  O Meyer; N Abuaf; L Cyna; J C Homberg; M F Kahn; A Ryckewaert
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

6.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

8.  Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases.

Authors:  N Zurgil; R Bakimer; H M Moutsopoulos; A G Tzioufas; P Youinou; D A Isenberg; M Scheinberg; T Kveder; B Rozman; C Luderschmidt
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

9.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

Authors:  S Mouritsen; E Demant; H Permin; A Wiik
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.